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Background: Adolescence marks a period where depression will commonly onset. Twin studies show that genetic
influences play a role in how depression develops and changes across adolescence. Recent genome-wide association
studies highlight that common genetic variants – which can be combined into polygenic risk scores (PRS) – are also
implicated in depression. However, the role of PRS in adolescent depression and changes in adolescent depression is
not yet understood. We aimed to examine associations between PRS for five psychiatric traits and depressive
symptoms measured across adolescence using cross-sectional and growth-curve models. The five PRS were as
follows: depression (DEP), major depressive disorder (MDD), anxiety (ANX), neuroticism (NEU) and schizophrenia
(SCZ). Methods: We used data from over 6,000 participants of the Avon Longitudinal Study of Parents and Children
(ALSPAC) to examine associations between the five PRS and self-reported depressive symptoms (Short Mood and
Feelings Questionnaire) over 9 occasions from 10 to 24 years. The PRS were created from well-powered genome-wide
association studies conducted in adult populations. We examined cross-sectional associations between the PRS at
each age and then again with longitudinal trajectories of depressive symptoms in a repeated measures framework
using multilevel growth-curve analysis to examine the severity and the rate of change. Results: There was strong
evidence that higher PRS for DEP, MDD and NEU were associated with worse depressive symptoms throughout
adolescence and into young adulthood in our cross-sectional analysis, with consistent associations observed across
all nine occasions. Growth-curve analyses provided stronger associations (as measured by effect sizes) and additional
insights, demonstrating that individuals with higher PRS for DEP, MDD and NEU had steeper trajectories of
depressive symptoms across development, all with a greater increasing rate of change during adolescence. Evidence
was less consistent for the ANX and SCZ PRS in the cross-sectional analysis, yet there was some evidence for an
increasing rate of change in adolescence in the growth-curve analyses with the ANX PRS. Conclusions: These results
show that common genetic variants as indexed by varying psychiatric PRS show patterns of specificity that influence
both the severity and rate of change in depressive symptoms throughout adolescence and then into young adulthood.
Longitudinal data that make use of repeated measures designs have the potential to provide greater insights how
genetic factors influence the onset and persistence of adolescent depression. Keywords: Polygenic risk scores;
depressive symptoms; longitudinal; trajectories; ALSPAC; adolescence; development.
Introduction
Depression is a common mental health disorder and
predicted to be the highest global burden of disease
by 2030 (WHO, 2012). Adolescence marks a period
where depressive symptoms increase and major
depressive disorder will commonly onset (Kessler,
Avenevoli, & Merikangas, 2001; Kessler et al., 2005;
Malhi & Mann, 2018; Rohde, Lewinsohn, Klein,
Seeley, & Gau, 2013). Adolescent depressive symp-
toms and major depressive disorder are associated
with a number of psychiatric and social impairments
in later life and show strong continuity with depres-
sion in adult life, thus making it important to prevent
and treat (Copeland, Shanahan, Costello, & Angold,
2009; Copeland, Wolke, Shanahan, & Costello,
2015; Fergusson, Boden, & Horwood, 2007; Rutter,
Kim-Cohen, & Maughan, 2006).
Depression has a complex and multifactorial aeti-
ology, comprised of both environmental and genetic
contributions (Flint & Kendler, 2014; Thapar, Collin-
shaw, Pine, & Thapar, 2012). Adult twin studies have
estimated that the heritability of major depressive
disorder is between 31% and 42% (Sullivan, Neale, &
Kendler, 2000). Twin studies of adolescent depressive
symptoms have estimated similar heritability to adult
depression, with a range most likely between 30%
and 50%, with lower estimates reported for symptoms
during childhood (Glowinksi, Madden, Bucholz, Lyns-
key, & Heath, 2003; Rice, 2014). However, there is
considerable variability in heritability estimates
between studies (11–72%) depending on age, sex,
informant and measure of assessment (Rice, 2009).
Depressive symptomatology typically increases dur-
ing adolescence, and twin studies have shown that
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genetic contributions influence this developmental
change (Hannigan, Walaker, Waszczuk, McAdams, &
Eley, 2017). In particular, genetic contributions may
increase throughout development (Bergen, Gardner,
& Kendler, 2007; Rice, Harold, & Thapar, 2002)
although some inconsistent results have also been
reported (Nivard et al., 2015). There are strong
continuities reported between adolescent and adult
depression (Rutter et al., 2006), so inconsistent
estimates of heritability for adolescent depressive
symptomatology are puzzling and may result from
between-study differences in measurement, infor-
mant and age. Longitudinal data spanning transi-
tions from early adolescence and young adulthood
using the same assessments and respondents over
time would aid understanding of the nature of genetic
influences on the onset and persistence of symptoms
across development.
Recent advances in genome-wide association stud-
ies (GWAS) have provided evidence that common
genetic variation plays a role in depression (Howard
et al., 2018, 2019; Wray et al., 2018) with many
genetic variants or single-nucleotide polymorphisms
(SNPs) each having a small effect (Mullins & Lewis,
2017). The heritability of depression estimated from
SNPs is ~9% in adults (Howard et al., 2019) and ~2%
in adolescents (Jami et al., 2020). However, this low
SNP heritability in adolescence partly reflects a
smaller GWAS sample size used and the varying
informants and greater measurement heterogeneity.
Polygenic risk scores (PRS), which sum the number
of ‘risk’ SNPs that an individual possesses for a trait
weighted by their effect size (Martin, Daly, Robinson,
Hyman, & Neale, 2018), can be used as an indicator
of an individual’s genetic liability to depression.
Several studies have used PRS taken from GWAS of
psychiatric traits in adult populations to investigate
how they associate with depressive symptomatology
across development in younger populations (Hall-
dorsdottir et al., 2019; Kwong, Lopez-Lopez, et al.,
2019; Rice et al., 2018; Riglin et al., 2018). One
study found that a higher PRS for major depressive
disorder (MDD) was associated with depression in
both clinical and population cohorts of children and
adolescents (Halldorsdottir et al., 2019), whilst
another found that the influence of an MDD PRS
on emotional problems increased with age with
weaker effects in childhood which developed in
adulthood (Riglin et al., 2018). The same study also
found that a higher PRS for schizophrenia was
associated with higher emotional problems in child-
hood. Similar results were observed in a separate
study which found that a greater PRS for MDD was
associated with both early and later adolescent-
onset trajectories of depression, whilst a higher
schizophrenia PRS was only associated with an early
adolescent-onset trajectory (Rice et al., 2018).
Together, these studies highlight that polygenic risk
is likely to play a role in the development and
maintenance of adolescent depression. Additionally,
other traits such as anxiety and neuroticism are
genetically correlated with depression (Luciano
et al., 2018; Purves et al., 2020), implying shared
genetic aetiology underlying these traits. However, it
is still unclear if these genetic factors that show
correlations with depression (i.e. anxiety; neuroti-
cism), also uniformly impact on how depression
manifests across development. Alternatively, there
may be differential effects on developmental depres-
sion that are specific to each genetic factor/liability
to a trait. Examining how and when PRS for different
traits impact on depression developmentally could
enhance our understanding of the mechanisms
underlying depression and how this varies across
developmental stages.
There is evidence that PRS are associated with
changes across childhood and adolescence for other
traits such as height (Paternoster et al., 2011) and
BMI (Khera et al., 2019; Warrington, Howe, et al.,
2013). These studies have used a repeated measures
framework that estimates trajectories or growth
curves to examine genetic associations with changes
in a trait. Using a repeated measures framework
such as growth-curve modelling may help improve
the statistical power of genetic analysis (Lubke et al.,
2016). Measurement error and low statistical power
are problems in genomic analysis as genetic effects
tend to be small in magnitude and require large
sample sizes with precision to detect true effects
(Hatoum, Rhee, Corley, Hewitt, & Friedman, 2018).
Likewise, variation in the reported genetic compo-
nent for depression may be partially a result of
differential phenotypic measurement error at differ-
ent occasions (Rice, 2014). A longitudinal approach
which uses repeated measures may reduce pheno-
typic measurement error and increase statistical
power as there are multiple occasions included in
the analysis, rather than just one occasion (Taylor,
Simpkin, Haycock, Dudbridge, & Zuccolo, 2016).
Indeed, a recent study using an MDD PRS found
higher heritability and variance explained by the
PRS when utilising a repeated measures framework
(Cheesman, 2018). Thus, multiple measurements
may obtain a more precise estimate of an individual’s
‘true’ latent trait score as the assessment is repeated
over time, and not just on one occasion. Using
repeated measurements, it is also possible to reduce
the burden for multiple testing that would occur
when looking at associations across timings in a
growth-curve setting as a number of multiple com-
parisons are reduced (Warrington, Wu, et al., 2013).
Repeated measures analysis, in particular growth-
curve modelling, may provide an advantage to tradi-
tional cross-sectional analysis and also quantify how
and when a trait changes over time, which in this
context could help further explain the role of genetic
liability in how and when adolescent depression
changes over time.
The aim of this study was to examine how genetic
liability for five genetically correlated psychiatric
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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traits (as indexed by PRS) influenced depressive
symptoms across adolescence and early adult life
using cross-sectional and repeated measures
designs. Specifically, we aimed to test how PRS for
depression (DEP; aka broad depression), major
depressive disorder (MDD), anxiety (ANX), neuroti-
cism (NEU) and schizophrenia (SCZ) were all asso-
ciated with both the initial level and the rate of
change of depressive symptoms over this develop-
mental risk period. We conducted the following
analyses: (a) we created five PRS taken from recent
GWAS (using clumping and thresholding methods)
and examined univariate associations at nine occa-
sions in a UK-based population cohort between the
ages of 10 and 24 years old (cross-sectional analy-
sis); (b) we then used growth-curve modelling to
construct trajectories of depressive symptoms in the
same cohort and examined how the five PRS were
associated with the rate of change in depressive
symptoms throughout adolescent development; and
(c) finally, we examined if higher PRS for each trait
were associated with differences in depressive symp-
toms scores compared to the population average PRS
in order to determine when each PRS was most
strongly associated with depressive symptomology.
Methods
Sample
We used data from the Avon Longitudinal Study of Parents and
Children (ALSPAC), a longitudinal cohort study that recruited
pregnant women residing in the former area of Avon, UK, with
expected dates of delivery 1st April 1991 to 31st December
1992 (Boyd et al., 2013; Fraser et al., 2013). The initial cohort
consisted of 14,062 live births, but has been increased to
14,901 children who were alive after one year with further
recruitment (Northstone et al., 2019). Ethical approval was
obtained from the ALSPAC Ethics and Law Committee and the
Local Research Ethics Committees. The study website contains
details of all the data that are available through a fully
searchable data dictionary and variable search tool: http://
www.bristol.ac.uk/alspac/researchers/our-data. A flow dia-
gram highlighting the study sample is given in Figure S1.
Depressive symptoms
Self-reported depressive symptoms were measured on nine
occasions between ages 10 and 24 using the Short Mood and
Feelings Questionnaire (SMFQ) (Angold, Costello, Messer, &
Pickles, 1995). The SMFQ is a 13-item questionnaire that
measures the presence of depression symptoms in the previ-
ous two weeks and was administered via postal questionnaire
or in research clinics. Each item is scored between 0 and 2,
resulting in a summed score between 0 and 26. See Table 1 for
the means, age range and alpha scores for each SMFQ
assessment. The SMFQ correlates highly (r = .58) with clinical
depression (Thapar & McGuffin, 1998; Turner, Joinson,
Peters, Wiles, & Lewis, 2014).
Polygenic risk scores
Five PRS were created with PRSice-2 (Choi & O’Reilly, 2019),
using summary statistics from five recent genome-wide
association studies (GWAS): depression (aka broad depression)
or DEP (Howard et al., 2019), major depressive disorder or
MDD (Wray et al., 2018), anxiety or ANX (Purves et al., 2020),
neuroticism or NEU (Luciano et al., 2018), and schizophrenia
or SCZ (Schizophrenia Working Group of the Psychiatric
Genomics Consortium, Ripke, Walters, & O’Donovan, 2020).
ALSPAC was not included in any of these GWAS. All PRS were
created by weighting the effect sizes of the single-nucleotide
polymorphisms (SNPs) associated with each trait from the
initial GWAS at nine p-value thresholds (PT: 5 9 1008,
5 9 1007, 5 9 1006, 5 9 1005, .0005, .005, .05, .5 and 1).
The number of SNPs included at each of these PRS thresholds
is given in Table S1. Each PRS was standardised to have a
mean of 0 and a standard deviation of 1; thus, a higher PRS
represents higher genetic liability to each trait. We included
SNPs that had a MAF of >1% and info score of >80% and
excluded SNPs with an R2 of >0.1 if they were within 250 kb of
each other. This was to account for linkage disequilibrium (LD)
so that only the most strongly associated SNPs from each
region were retained. Complete genotyping information is
available in the Supporting Information.
Statistical analysis
For the cross-sectional analyses, regression was performed
within PRSice-2 to examine the association between each of
the five PRS and depressive symptoms at each of the nine
occasions. p-values were corrected using the Benjamini–
Yekutieli method for multiple testing (pBY) due to the number
of related tests (five PRS 9 nine PRS thresholds 9 nine occa-
sions of depressive symptoms [405 tests]). Empirical p-values
(with 1,000 permutations) were also calculated to examine
within PRS associations between the nine occasions of depres-
sive symptoms at each of the nine PRS thresholds (e.g. DEP
PRS 9 nine PRS thresholds 9 nine occasions of depressive
symptoms). Sex and the first 10 principal components of
ancestry were included as covariates.
For the repeated measures analysis, trajectories of depres-
sive symptoms were estimated using multilevel growth-curve
modelling (Hedeker & Gibbons, 2006; Raudenbush & Bryk,
2002). Briefly, multilevel growth-curve models create popula-
tion averaged trajectories with intercept and slope terms.
Individual-level trajectories then vary around this population
average (i.e. each person can have their own trajectory, with
their own intercept and slope that can deviate from the
population average). Previous analysis of these data has shown
that changes in depressive symptoms over time are nonlinear
(Edwards et al., 2014; Kwong, Manley, et al., 2019), with
depressive symptoms rising until the age of about 18, then
decreasing until around the age of 22, before rising again
towards the age of 24. To model these nonlinear trajectories, a
multilevel quartic growth-curve polynomial model was chosen.
This model contains five key parameters: the intercept, the
linear age term, the quadratic age term, the cubic age term and
the quartic age term. These age terms allow for nonlinearity in
the trajectory and changes in depressive symptoms. Previous
research using these data to estimate multilevel growth curves
has found higher order polynomials best fitted the data
(Kwong, Manley, et al., 2019). We further assessed the fit of
this model using information criteria and likelihood ratio tests,
consistent with other studies using multilevel growth-curve
models (Singer & Willett, 2003) – see Tables S2 and S3, and
Figure S2.
To examine how each PRS was associated with changes in
depressive symptoms, we included a main effect of each
standardised PRS and an interaction of the PRS with each of
the fixed-effects age polynomial terms (i.e. linear, quadratic,
cubic and quartic age terms). Age was grand-mean centred to
16.53 years (the mean age of all assessments) in order to
improve interpretation, since model intercept and intercept
variance then broadly correspond to the middle of adolescence
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
PRS and trajectories of depressive symptoms 3
(Rawana & Morgan, 2014). The intercept and four polynomial
age terms were allowed to vary randomly across individuals to
capture each individual’s unique trajectory (i.e. a random
intercept and random slopes model). Each psychiatric PRS was
run univariately, and further information regarding model fit
and model equations are given in the Supporting Information.
To assess the association between each psychiatric PRS and
development of symptoms over time, we created a population
average trajectory which was comprised of the mean PRS for
the sample, a trajectory associated with lower genetic liability
(1 SD below mean in PRS) and one trajectory associated with
higher genetic liability (1 SD above the mean in PRS). We
calculated the predicted depressive symptoms scores at each
of the following ages: 10.63, 12.80, 13.83, 16.68, 17.82, 18.64,
21.94, 22.87 and 23.88 (to coincide with the mean ages at
which the SMFQ was assessed at each of the nine occasions)
for the population average, greater liability, and lower liability
PRS trajectories. We then compared the predicted depressive
symptoms scores at each of these ages between the population
average trajectory and the higher genetic risk PRS trajectory
(i.e. to compare greater genetic risk for each PRS compared to
the population average). Further information on how these
were calculated for the trajectories is presented elsewhere
(Kwong, Maddalena, Croft, Heron, & Leckie, 2019). Briefly, the
depressive symptoms scores were calculated at each age for
the two trajectories (i.e. depressive symptom scores at age
12.80 for the population mean and then for the higher PRS
[+1SD] trajectory). The delta method (which incorporates the
estimate, standard errors and confidence intervals) was then
used to compare these two scores revealing a predicted
difference in scores that are derived estimates from each
trajectory – thus utilising the repeated nature of the measures
to obtain a more accurate estimate. p-values were corrected for
using false discovery rate (pFDR). Stata code for our analysis
can be found here: https://github.com/kwongsiufung/prs-tra
jectories. Repeated measures analyses were conducted using
Stata 15 (StataCorp, College Station, TX, USA), using the user-
written runmlwin command (Leckie & Charlton, 2013), which
calls the standalone multilevel modelling package MLwiN
v3.01 (www.cmm.bristol.ac.uk/MLwiN/index.shtml). These
analyses were adjusted for sex and the first ten principal
components of ancestry.
Missing data
Missing data in the trajectories analysis were handled using
full information maximum likelihood estimation (FIML) (Cur-
ran & Hussong, 2003). Briefly, this assumes that the proba-
bility of an individual missing a measure of depressive
symptoms does not depend on their underlying depressive
symptoms score at that occasion, given their observed depres-
sive symptoms trajectory at other occasions. We included
individuals into our analysis if they had at least one measure-
ment of depression symptoms in order to maximise power
(Lopez-Lopez et al., 2019). Further information regarding the
characteristics of this sample has been described in other
work (Kwong, 2019). Previous research on these data has
shown that trajectory shapes and characteristics do not vary
when comparing individuals with at least one or at least 4
measurements of depressive symptoms (Kwong, Manley, et al.,
2019).
Sensitivity analyses
We conducted a variety of sensitivity analyses, as follows. (a) To
ensure any benefits of the repeated measures analyses were
not due to well-powered GWAS, we ran sensitivity analyses
substituting our five psychiatric PRS with two well-powered
traits: educational attainment (EA) and height (HEI). We
supplemented this by further examining the impact of the five
psychiatric PRS on trajectories of height. (b) Given the
complexity of our growth curve and the risk over fitting the
model, we also estimated a simpler quadratic trajectory with
each of the five PRS and calculated the predicted scores for
different trajectories in a similar manner to the main analyses.
(c) We conducted tests for measurement invariance for depres-
sive symptoms over time (highlighted in Figure S3). (d) We ran
analysis exploring the association between the DEP PRS and
missing data patterns (shown in Figure S4). Further informa-




Of the original 14,901 children alive after one year,
9,399 had at least one measurement of depressive
symptoms and 7,877 had genotype data that passed
quality control (see the Supporting Information). For
the cross-sectional analysis, data were available for
5,317 individuals with a measurement of depressive
symptoms at age 10.63 and genotype data, decreas-
ing to 2,737 at age 23.88 (see Table S4). For the
repeated measures analysis, data were available for
Table 1 Descriptive statistics of the Short Mood and Feelings Questionnaire (SMFQ) for individuals included in this analysis
Occasion (Total N) Mean age Mean SMFQ Alpha % Above SMFQ thresholda
1 (N = 5,317) 10.63 (0.25) 4.00 (3.49) .80 5.85
2 (N = 4,923) 12.80 (0.23) 3.94 (3.84) .84 7.11
3 (N = 4,492) 13.83 (0.21) 4.92 (4.49) .86 11.81
4 (N = 3,521) 16.68 (0.24) 5.85 (5.63) .91 17.68
5 (N = 3,210) 17.82 (0.37) 6.50 (5.21) .90 21.05
6 (N = 2,387) 18.64 (0.49) 6.73 (5.85) .91 21.20
7 (N = 2,377) 21.94 (0.52) 5.56 (5.46) .91 17.44
8 (N = 2,704) 22.87 (0.51) 6.07 (5.40) .90 17.64
9 (N = 2,737) 23.88 (0.51) 6.84 (5.91) .91 23.49
Standard deviations are given in (parenthesis).
aScores equal to or above 11 have been proposed as good indicators of depression (Turner et al., 2014). Individuals included in this
analysis had data on the SMFQ, genetic data to make the PRS/principal components of ancestry and data on sex. Alpha scores were
estimated using Cronbach’s alpha.
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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6,302 individuals with at least one measurement of
depressive symptoms, sex and genotype data.
Cross-sectional associations between polygenic risk
scores and depressive symptoms
Figure 1 shows a summary of results from the five
psychiatric PRS across all nine ages of depressive
symptoms, using the best predictive threshold for
each PRS. For the associations between each PRS
and depressive symptoms, we present timings that
correspond to measures in three key periods early
adolescence, late adolescence and early adulthood
for brevity. Full estimates and the best predictive
PRS for each trait at each age are given in Tables S5–
S19. A higher PRS for DEP was associated with
higher depressive symptoms across all nine occa-
sions (Tables S5–S7). Effect sizes and the amount of
variance explained by the DEP PRS generally
increased throughout development with smaller
estimates at age 10.63 (b = .208, 95%CIs = 0.116,
0.301, R2 = 0.37%, pBY = .0004) compared to age
17.82 (b = .583, 95%CIs = 0.410, 0.757,
R2 = 1.30%, pBY = 1.55 9 10
08) and then age
23.88 (b = .864, 95%CIs = 0.650, 1.079,
R2 = 2.21%, pBY = 5.29 9 10
12). A similar pattern
was observed for the MDD PRS, although the effect
sizes and the variance explained were smaller at
later ages compared to the DEP PRS (age 10.63:
b = .222, 95%CIs = 0.128, 0.317, R2 = 0.40%,
pBY = .0002; age 17.82: b = .405, 95%CIs = 0.224,
0.587, R2 = 0.58%, pBY = .0005; age 23.88: b = .646,
95%CIs = 0.430, 0.863, R2 = 1.22%,
pBY = 5.86 9 10
07, Tables S8–S10). Effects were
less consistent for the ANX PRS, which showed
smaller effect sizes and a lower variance explained
compared to the DEP PRS, but still evidence of
greater effects over time (age 10.63: b = .128, 95%
CIs = 0.034, 0.222, R2 = 0.13%, pBY = .109; age
17.82: b = .469, 95%CIs = 0.296, 0.641,
R2 = 0.85%, pBY = 6.86 9 10
06; age 23.88:
b = .682, 95%CIs = 0.470, 0.894, R2 = 1.41%,
pBY = 7.53 9 10
08, Tables S11–S13). The NEU
PRS showed comparable associations, effect sizes
and variance explained compared to the DEP and
MDD PRS at age 10.63 (b = .240, 95%CIs = 0.147,
0.333, R2 = 0.48%, pBY = 2.13 9 10
05) and age
17.82 (b = .559, 95%CIs = 0.385, 0.733,
R2 = 1.19%, pBY = 7.53 9 10
08), but the strongest
associations of all the PRS at age 23.88 (b = .919,
95%CIs = 0.703, 1.135, R2 = 2.45%,
pBY = 3.52 9 10
13, Tables S14–S16). In contrast,
the SCZ PRS showed relatively low effect sizes and
variance explained compared to the other PRS (age
10.63: b = .112, 95%CIs = 0.019, 0.205,
R2 = 0.10%, pBY = .224; age 17.82: b = .271, 95%
CIs = 0.094, 0.448, R2 = 0.27%, pBY = .048; age
23.88: b = .292, 95%CIs = 0.073, 0.511,
R2 = 0.25%, pBY = .127, see Tables S17–S19).
Associations between polygenic risk scores and
trajectories of depressive symptoms and
comparisons between population average PRS
trajectories and higher PRS trajectories (+1 SD)
The cross-sectional analyses revealed that on aver-
age more liberal PRS thresholds (PT: 0.0005 to 1)
explained more of the variance in depressive symp-
toms across ages compared to more stringent PRS
thresholds (PT: 5 9 1008 to 5 9 1005, Tables S6,
S9, S12, S15 and S18). Consequently, we focused on
estimating trajectories with more liberal PRS thresh-
olds for each of the five psychiatric PRS. The best
model fit – assessed by lowest deviance – was then
used to determine which PRS threshold to compare
population average PRS trajectories with higher PRS
trajectories (i.e. those with a +1 SD in PRS) for each of
the psychiatric PRS traits.
There was evidence that higher psychiatric PRS
were associated with greater depressive symptoms
scores at the intercept age of 16.53 for the DEP PRS
(b = .419, 95%CIs = 0.286, 0.551,
p = 5.79 9 1010), MDD PRS (b = .426, 95%
CIs = 0.292, 0.559, p = 4.79 9 1010), ANX PRS
(b = .291, 95%CIs = 0.159, 0.423, p = 1.0 9 1005),
NEU PRS (b = .550, 95%CIs = 0.419, 0.681,
p = 2.22 9 1016) and SCZ PRS (b = .149, 95%
CIs = 0.016, 0.283, p = 0.029). However, only the
DEP PRS (b = .062, 95%CIs = 0.030, 0.094,
p = 0.0001), MDD PRS (b = .064, 95%CIs = 0.032,
0.096, p = 0.0001) and NEU PRS (b = .041, 95%
CIs = 0.009, 0.072, p = 0.012) showed consistent
evidence for linear change over time. There was no
evidence that any of the psychiatric PRS showed
meaningful changes over time for the quadratic,
cubic and quartic age terms (Tables S20–S24).
All five psychiatric PRS showed that trajectories
were higher for those with greater genetic liability to
a trait (+1 SD in PRS) compared to those with the PRS
population average (Figure 2). However, only the
DEP, MDD, ANX and NEU PRS showed predicted
differences in depressive symptoms scores that
substantially increased across development
(Table 2). There was no consistent evidence that
the predicted differences in SCZ PRS increased over
time as differences tended to remain small and
stable. The predicted depressive symptoms scores
at each age and for each trajectory are given in
Table S25.
Sensitivity analyses
There was evidence that a higher EA PRS was
associated with lower trajectories of depressive
symptoms, indexed by multiple rate of change
parameters (Table S26). However, this gave incon-
sistent estimates when comparing the predicted
differences in depressive symptoms scores between
trajectories for those with greater genetic liability to
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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EA and those with the population average PRS
(Table 2). There was no evidence that a greater HEI
PRS was associated with trajectories of depressive
symptoms or predicted differences in scores between
higher genetic liability and the population average
(Table 2 and Table S27). The predicted scores for
both EA and HEI PRS and their trajectories are given
in Table S28 and Figure S5. Furthermore, there was
no evidence that any of the psychiatric PRS were
associated with trajectories of height (Table S29 and
Figure S6), nor any substantive differences when
rerunning the analyses with quadratic trajectories of
depressive symptoms (Tables S30–S31 and Fig-
ure S7). Tests for measurement invariance suggested
there was weak measurement invariance between
age 10.63 and age 23.88 (difference between models:
x2 = 355.68, df = 12, p < .0001). However, even
when taking measurement variance into account,
there was still a stronger association between the
DEP PRS and depressive symptoms at age 23.88
(b = .146, 95 CIs = 0.107, 0.185, p < .001), com-
pared to age 10.63 (b = .075, 95 CIs = 0.044, 0.106,
p < .001) suggesting the association between the
DEP PRS and depressive symptoms at age 23.88
reflects a stronger association between the PRS and
that depressive symptoms construct, rather than an
artefact of measurement variance (Tables S32–S34).
Finally, there was evidence that higher PRS for all
psychiatric PRS were associated with more missed
assessments of depressive symptoms, whereas
higher PRS for EA and HEI were associated with less
missed assessments (Table S35). Further
information on all analyses is provided in the Sup-
porting Information.
Discussion
In this longitudinal cohort study, we examined
multiple cross-sectional analysis at different ages
and a growth-curve modelling approach that utilised
a repeated measures framework to explore associa-
tions between five psychiatric PRS and depressive
symptoms across adolescence. In cross-sectional
analysis, we found consistent evidence that higher
PRS for DEP, MDD and NEU were associated with
greater levels of depressive symptoms throughout all
of adolescence and early adulthood. There were
stronger associations between the PRS and depres-
sive symptoms at older ages that were not explained
by measurement invariance. In the growth-curve
analysis, we found that higher PRS for DEP, MDD
and NEU were strongly associated with steeper
trajectories of depressive symptoms. The PRS were
associated with trajectories characterised by greater
overall depressive symptoms across adolescence, as
well as a greater increase in the rate of change of
depressive symptoms from early adolescence to early
adulthood. There was some evidence that higher
ANX PRS were associated with steeper trajectories of
depressive symptoms, but these effects were less
consistent than the DEP, MDD and NEU PRS. There
was less evidence that SCZ PRS were associated with
greater levels of depressive symptoms or changes in
depressive symptoms across development.
Our results suggest that individuals with higher
PRS for DEP, MDD, NEU and to some extent ANX are
associated with greater depressive symptoms in
adolescence and early adulthood and may influence
how depressive symptoms change across adoles-
cence and adulthood. Importantly, we see that
higher PRS for these psychiatric traits begin to have
higher symptoms scores that emerge between the
ages of 12 and 14, suggesting that genetic liability
may play a role in the onset of adolescent depression
and that this is similar for traits that are genetically
correlated and comorbid with depression (i.e. anxiety
and neuroticism) – thus implying a shared genetic
aetiology may underpin these results. Our results
are consistent with research in high-risk family
studies (Weissman et al., 2006), and place further
emphasis on the idea that depression is not only
heritable, but genetic liability may also influence the
rate of phenotypic change that is expressed (in this
case depressive symptoms across adolescence and
young adulthood). Furthermore, the predicted dif-
ferences between higher genetic risk trajectories and
the population average PRS generally increased
throughout development, suggesting that higher
genetic liability to depression or neuroticism may
also influence the maintenance or persistence of
worse depressive symptoms across time as well.
There was, however, some specificity towards
Figure 1 Cross-sectional analysis between the most predictive PRS
for each trait and depressive symptoms across adolescence and
early adulthood. ANX, anxiety; DEP, depression (broad depres-
sion); MDD, major depressive disorder; NEU, neuroticism; PRS,
polygenic risk score; SCZ, schizophrenia. SMFQ, Short Mood and
Feelings Questionnaire (depressive symptoms). Analyses were
adjusted for sex, age and the first ten principal components of
ancestry. The most predictive PRS for each trait had p-value
thresholds (PT) that varied between 5 9 1008 and 1. These are
described in full in Supporting Information.* indicates results
were significant after Benjamini–Yekutieli correction to control
for the number of related multiple tests (405 related tests)
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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affective disorders, with little evidence for an asso-
ciation with genetic liability for nonaffective domains
(i.e. schizophrenia or educational attainment).
Our repeated measures analyses suggested that
the DEP, MDD and NEU PRS had stronger associa-
tions as age increased and that differences in
trajectories could be partially the result of increased
genetic liability to specific psychiatric traits across
development. This is consistent with longitudinal
twin research showing the genetic contribution to
depression increases throughout adolescent devel-
opment (Bergen et al., 2007; Rice et al., 2002) and to
some extent research across the life course (Nivard
et al., 2015). Together, these results suggest that
genetic factors influence how depressive symptoms
manifest at different stages of development, but
importantly they also demonstrate when depressive
symptoms may be more sensitive to genetic or
environmental factors. Our results showed the
impact of DEP, MDD and NEU PRS on depressive
symptoms generally increased with age supporting
the idea that the manifestation of the genetic archi-
tecture of depression is not stable (Riglin et al.,
2018). Further evidence that utilises depression and
genetic data measured across childhood, adoles-
cence and later stages of adulthood is required to
further enhance our understanding of developmen-
tal depression and the role of genetic and environ-
mental influences.
There are several possible explanations as to why
genetic liability may influence change over time.
First, genetic liability to depression and correlated
traits like anxiety and neuroticism may act upon
biological and hormonal pathways, especially during
adolescence (Paus, Keshavan, & Giedd, 2008). This
may result in changes to brain development and
hormonal responses that put an individual at greater
risk of depression (Blakemore, 2008). Second, gene
environment correlation with key environmental risk
exposures such as stressful life events may increase
with age (Jaffee & Price, 2012; Rice, Harold, &
Thapar, 2003; Thapar et al., 2012). This in turn
may produce indirect pathways to depression that
are a result of increased environmental exposures
that occur in later development. Third, differences in
genetic liability could be the result of measurement
error and statistical noise at the varying occasions,
but these may be reduced in repeated measures
designs (Lubke et al., 2016). Thus, a repeated
measures design that incorporates genetic data
may be a more useful model for exploring the
temporal association between genetic risk and a
complex developing phenotype.
Previous research has shown that PRS can be
included into longitudinal models that examine
change over time (Khera et al., 2019; Paternoster
et al., 2011; Warrington, Howe, et al., 2013).
Research has suggested that it is also possible to
examine genetic influences on age-related changes
in depression (Lubke et al., 2016). We were able to
expand upon previous work to examine genetic
contributions to varying trajectories of depressive
symptoms, but specifically in this study we were able
to demonstrate how phenotypic manifestations of
genetic liability (as indexed by PRS) vary by age. We
demonstrated that genetic influences may be age-
Figure 2 Association between the five psychiatric PRS and trajectories of depressive symptoms. ANX, anxiety; DEP, depression (broad
depression); MDD, major depressive disorder; NEU, neuroticism; PRS, polygenic risk score; SCZ, schizophrenina; SMFQ, Short Mood and
Feelings Questionnaire (depressive symptoms). Averaged population trajectories of depressive symptoms for greater and less genetic
liability (1 SD PRS) for each of the varying PRS compared the population average of the PRS (black line for all). Analyses were adjusted
for sex and the first ten principal components of ancestry
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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specific (i.e. may begin to onset at different times)
which enhances previous research looking at groups
of individuals. Our results highlight a useful
approach for a repeat measures framework (such
as a growth-curve model) to quantify the extent to
which genetics may influence traits over time (by
examining rate of change) which goes over and above
traditional cross-sectional research.
This study had several strengths. First, we were
able to use a large longitudinal population cohort
with repeated assessments of depressive symptoms
using the same measure and informant across
adolescence to adulthood. Many longitudinal studies
with this depth of data change measures or infor-
mants, yet we were able to utilise the same measures
and informants to characterise trajectories of
depressive symptoms across key transitional periods
of heightened vulnerability to depression. Second,
we were then able to expand upon previous research
by using a repeated measures model that is a
powerful alternative to cross-sectional analysis. By
using the correlation between the repeated measure-
ments, it may be possible to reduce measurement
error and boost statistical power, evidenced by the
stronger associations at varying ages in the growth-
curve analysis. Our negative control analysis exam-
ining the association between the PRS for height and
trajectories of depressive symptoms, and the five
psychiatric PRS for trajectories of height support this
claim and did not show any evidence for nonspecific
genomic predictors influencing unrelated trajecto-
ries. There was some evidence that a higher PRS for
educational attainment was associated with changes
over time, but this led to inconsistent differences
across development, which may not be surprising
given the genetic correlation with depression (Wray
et al., 2018). Third, we were also able to use the same
sample across our analysis as the repeated mea-
sures model used full-information maximum likeli-
hood (FIML) to account for missing data, which is an
advantage of this method compared to the cross-
sectional analysis which may require additional
methods for handling missing data. Fourth, we able
to examine the impact of multiple psychiatric PRS
from well-powered GWAS studies. To the best of our
knowledge, we show for the first time, a key role for
polygenic risk for anxiety and neuroticism in ado-
lescent depressive symptoms. Still, it is important to
state here that that anxiety GWAS had a much
smaller sample size than the other PRS, which most
likely explains the weaker associations.
However, this study had several limitations. First,
this study did suffer from attrition as sample sizes
varied across ages in the cross-sectional analysis,
which may bias our results as missingness is not
random. One of the advantages of using the repeat
measures model is that we can instead use FIML to
account for missing data. This approach also min-
imises the bias that may be present if each occasion
(age wave) represents a different sample. However,
even this approach may be biased if the data are
missing not at random. For example, genetic risk for
depression may predict missing assessments in
ALPSAC (Rice et al., 2018; Taylor et al., 2018). This
could lead to bias in this study and an underesti-
mation of the true estimate for the trajectories of
depressive symptoms and a further underestimation
of the genetic contributions to depressive symptoms.
We tested this in sensitivity analysis and found that
our five psychiatric PRS were associated with the
number of times an individual completed the depres-
sive symptoms, whilst higher EA and HEI PRS were
associated with more completed assessments. This
demonstrates there is likely to be some level of bias
between genetic liability to a trait and subsequent
attrition. Second, depression is a heterogeneous
condition and there may be a genetic difference
between sum scores, and specific symptoms of
depression (Nagel, Watanabe, Stringer, Posthuma,
& van der Sluis, 2018). Depression symptoms may
also differ at different ages (Rice et al., 2019). We
used the same summary score of depressive symp-
toms throughout our study, which therefore only
captures the sum of depressive symptoms and does
not highlight if certain symptoms of depression (i.e.
anhedonia, lack of appetite or depressive thoughts)
are more related to genetic liability for depressive
symptoms. Likewise, tests for measurement invari-
ance indicated that the responses to the depressive
symptoms questionnaire may have changed over
time, yet the stronger association between the DEP
PRS and later occasions was independent of mea-
surement variance. Nevertheless, future research
should look to examine how different profiles of
depression change across time and how these pro-
files are independently predicted by genetic risk.
Third, our results lack generalisability to all popu-
lations as the original GWAS (and subsequently this
analysis) was conducted on individuals of European
ancestry, and this may have consequences on
further clinical applications (Mostafavi, Harpak,
Conley, Pritchard, & Przeworski, 2019). However,
research is beginning to capture GWAS of non-
European populations (Bigdeli et al., 2017), and
future studies will be able to examine the impact of
genetic liability on adolescent depression in other
populations. Finally, whilst our results highlight a
potential role for PRS in understanding and exam-
ining pathways to depression (particularly as PRS
are based on genotypes and are at fixed at birth and
therefore less susceptible to reverse causation), the
amount of variance in depressive symptoms
explained by the PRS was low (never more than
2.45%). Whilst this is similar to the effect sizes
reported in previous work (Howard et al., 2019;
Luciano et al., 2018; Wray et al., 2018), the clinical
implications of these results are not clear and PRS
should continue to be used for making group-level,
rather than individual-level predictions at this stage
(Morris, Davies, & Davey Smith, 2020).
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In conclusion, we found evidence that PRS for
depression, major depressive disorder and neuroti-
cism were associated with depressive symptoms
from ages 10 to 24. These PRS and, to some extent,
anxiety were also associated with how depressive
symptoms change over time, providing evidence that
higher genetic liability to specific mood disorder
traits is associated with higher trajectories of depres-
sive symptoms (estimated via a higher intercept and
slope). Growth-curve models that use a repeated
measures framework may be a useful tool in genetic
analysis, providing greater statistical power/mea-
surement precision and the opportunity to examine
changes and variation in depression over time. Our
results add to the body of evidence that genetics play
a role in the onset and maintenance of adolescent
depression and highlight the potential importance of
this information for examining pathways to depres-
sion.
Supporting information
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Key Points
 Adolescent depression shows a strong heritable component, but it is unclear how genetic risk scores play a
role in the development and maintenance of depression across adolescence and beyond.
 The present study used a longitudinal design to examine the impact of five psychiatric polygenic risk scores
on depressive symptoms across nine occasions and then on trajectories of depressive symptoms in over 6,000
individuals. We also sought to test whether using a repeated measures framework could provide additional
insights beyond tradition cross-sectional methods.
 We found that individuals with greater genetic risk scores for depression, major depressive disorder and
neuroticism were associated with higher depressive symptoms across development and with more severe
trajectories of depressive symptoms across adolescence and young adulthood. Evidence was less clear for
anxiety and schizophrenia genetic risk scores.
 Our study highlights the role of genetic risk scores in the onset and maintenance of depressive symptoms
across development. Repeated measures designs may provide further insight into the relationship between
genetics and psychiatric outcomes.
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